PharmaEssentia (TWSE: 6446) today announced its net revenues for August 2025: On a consolidated basis, revenues for August 2025 were approximately NT$1.27 billion, a decrease of 2.14% from July 2025 and an increase of 41.35% from August 2024. The year-to-date consolidated revenue totaled NT$9.44 billion, an increase of 64.36%.